US loss of exclusivity · Immunology
Skyrizi
AbbVie
2033
US biosimilars from
2025
Today: 2026
2037
2025 worldwide sales
$17.6B
Date basis
Company guidance
US biosimilars
No US filing found
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Skyrizi timeline →